These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 19436686)

  • 1. The repeatability of interleukin-6, tumor necrosis factor-alpha, and C-reactive protein in COPD patients over one year.
    Kolsum U; Roy K; Starkey C; Borrill Z; Truman N; Vestbo J; Singh D
    Int J Chron Obstruct Pulmon Dis; 2009; 4():149-56. PubMed ID: 19436686
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systemic inflammation in patients with COPD and pulmonary hypertension.
    Joppa P; Petrasova D; Stancak B; Tkacova R
    Chest; 2006 Aug; 130(2):326-33. PubMed ID: 16899829
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biomarkers of systemic inflammation in stable and exacerbation phases of COPD.
    Karadag F; Karul AB; Cildag O; Yilmaz M; Ozcan H
    Lung; 2008; 186(6):403-9. PubMed ID: 18807087
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The value of C-reactive protein as a marker of systemic inflammation in stable chronic obstructive pulmonary disease.
    Karadag F; Kirdar S; Karul AB; Ceylan E
    Eur J Intern Med; 2008 Mar; 19(2):104-8. PubMed ID: 18249305
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Altered serum levels of type I collagen turnover indicators accompanied by IL-6 and IL-8 release in stable COPD.
    Zeng YY; Hu WP; Zuo YH; Wang XR; Zhang J
    Int J Chron Obstruct Pulmon Dis; 2019; 14():163-168. PubMed ID: 30655663
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of inflammation biomarkers among chronic obstructive pulmonary disease groups: A cross sectional study.
    Yazici O; Gulen ST; Yenisey C; Eryilmaz U; Abas BI; Polatli M
    Niger J Clin Pract; 2020 Jun; 23(6):817-824. PubMed ID: 32525117
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased serum TRAIL and DR5 levels correlated with lung function and inflammation in stable COPD patients.
    Wu Y; Shen Y; Zhang J; Wan C; Wang T; Xu D; Yang T; Wen F
    Int J Chron Obstruct Pulmon Dis; 2015; 10():2405-12. PubMed ID: 26609227
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relation between systemic inflammatory markers, peripheral muscle mass, and strength in limb muscles in stable COPD patients.
    Ferrari R; Caram LM; Faganello MM; Sanchez FF; Tanni SE; Godoy I
    Int J Chron Obstruct Pulmon Dis; 2015; 10():1553-8. PubMed ID: 26345641
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Associations between BODE index and systemic inflammatory biomarkers in COPD.
    Gaki E; Kontogianni K; Papaioannou AI; Bakakos P; Gourgoulianis KI; Kostikas K; Alchanatis M; Papiris S; Loukides S
    COPD; 2011 Dec; 8(6):408-13. PubMed ID: 22149400
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mixed Th2 and non-Th2 inflammatory pattern in the asthma-COPD overlap: a network approach.
    de Llano LP; Cosío BG; Iglesias A; de Las Cuevas N; Soler-Cataluña JJ; Izquierdo JL; López-Campos JL; Calero C; Plaza V; Miravitlles M; Torrego A; Martinez-Moragon E; Soriano JB; Viña AL; Bobolea I
    Int J Chron Obstruct Pulmon Dis; 2018; 13():591-601. PubMed ID: 29483774
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Skin condition and its relationship to systemic inflammation in chronic obstructive pulmonary disease.
    Majewski S; Pietrzak A; Tworek D; Szewczyk K; Kumor-Kisielewska A; Kurmanowska Z; Górski P; Zalewska-Janowska A; Piotrowski WJ
    Int J Chron Obstruct Pulmon Dis; 2017; 12():2407-2415. PubMed ID: 28860735
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation of severity of chronic obstructive pulmonary disease with potential biomarkers.
    Singh S; Verma SK; Kumar S; Ahmad MK; Nischal A; Singh SK; Dixit RK
    Immunol Lett; 2018 Apr; 196():1-10. PubMed ID: 29329680
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The influence of inflammatory process on the ventilatory impairment in patients with stable chronic obstructive pulmonary disease].
    Komnata K
    Pneumonol Alergol Pol; 2010; 78(4):271-8. PubMed ID: 20665447
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systemic inflammation in chronic obstructive pulmonary disease: a population-based study.
    Garcia-Rio F; Miravitlles M; Soriano JB; Muñoz L; Duran-Tauleria E; Sánchez G; Sobradillo V; Ancochea J;
    Respir Res; 2010 May; 11(1):63. PubMed ID: 20500811
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dynamic pulmonary hyperinflation and low grade systemic inflammation in stable COPD patients.
    Gatta D; Aliprandi G; Pini L; Zanardini A; Fredi M; Tantucci C
    Eur Rev Med Pharmacol Sci; 2011 Sep; 15(9):1068-73. PubMed ID: 22013730
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circulating vascular endothelial growth factor and systemic inflammatory markers in patients with stable and exacerbated chronic obstructive pulmonary disease.
    Valipour A; Schreder M; Wolzt M; Saliba S; Kapiotis S; Eickhoff P; Burghuber OC
    Clin Sci (Lond); 2008 Oct; 115(7):225-32. PubMed ID: 18307413
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma leptin and adiponectin in COPD exacerbations: associations with inflammatory biomarkers.
    Krommidas G; Kostikas K; Papatheodorou G; Koutsokera A; Gourgoulianis KI; Roussos C; Koulouris NG; Loukides S
    Respir Med; 2010 Jan; 104(1):40-6. PubMed ID: 19782551
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical significance of nuclear factor erythroid 2-related factor 2 in patients with chronic obstructive pulmonary disease.
    Ban WH; Kang HH; Kim IK; Ha JH; Joo H; Lee JM; Lim JU; Lee SH; Rhee CK
    Korean J Intern Med; 2018 Jul; 33(4):745-752. PubMed ID: 29529843
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Correlation among the levels of C-reactive protein and interleukin-18, quality of life, and lung function in patients with chronic obstructive pulmonary disease].
    Long H; Luo H; Chen P; Li Y
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2011 Nov; 36(11):1090-6. PubMed ID: 22169727
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The relationship between inflammatory markers and disability in chronic obstructive pulmonary disease (COPD).
    Garrod R; Marshall J; Barley E; Fredericks S; Hagan G
    Prim Care Respir J; 2007 Aug; 16(4):236-40. PubMed ID: 17665081
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.